A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study.

Autor: Jacquinot, Quentin1,2,3 quentin.jacquinot@edu.univ-fcomte.fr, Meneveau, Nathalie3, Chatot, Marion4, Bonnetain, Franck5, Degano, Bruno2,6, Bouhaddi, Malika2,6, Dumoulin, Gilles2,7, Vernerey, Dewi5, Pivot, Xavier3, Mougin, Fabienne1,2
Zdroj: BMC Cancer. 6/19/2017, Vol. 17, p1-11. 11p. 3 Diagrams, 1 Chart.
Databáze: Academic Search Ultimate